Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Virus-based gene therapy research, and CAR-T cell therapy research.
Integrated analysis of somatic mutations and immune microenvironment in malignant pleural mesothelioma
<scp>TOPK</scp> (T‐<scp>LAK</scp> cell‐originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer
Myasthenic crisis and polymyositis induced by one dose of nivolumab
Intratumoral expression levels of <i>PD-L1</i>, <i>GZMA</i>, and <i>HLA-A</i> along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma
Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer
Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells